BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$3.89 -0.05 (-1.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Non Operating Investment Income (2024 - 2026)

Updated

BridgeBio Oncology Therapeutics (BBOT) recorded Non Operating Investment Income of -$997,000 in Q1 2026, compared with -$157,000 a year earlier.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Non Operating Investment Income (2024 - 2026) Analysis & Trends

On a TTM basis, BridgeBio Oncology Therapeutics' Non Operating Investment Income came in at -$1.35 million as of Mar 31, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 BridgeBio Oncology Therapeutics 311.65 Mn -1.06 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -997,000.00
Jun 30, 2025 -140,000.00
Mar 31, 2025 -157,000.00
Jun 30, 2024 -59,000.00
API Access

BridgeBio Oncology Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=BBOT&period=max&api_key=YOUR_API_KEY